Skip to main content
Clinical Trials/JPRN-jRCT2080224618
JPRN-jRCT2080224618
Completed
Phase 1

A three-way crossover study to assess the relative bioavailability of 1-mg and 4-mg tablets of S-888711 and the effect of high-fat meals on the pharmacokinetics of the 4-mg tablet in healthy male subjects

SHIONOGI & CO., LTD.0 sites15 target enrollmentMarch 28, 2019

Overview

Phase
Phase 1
Intervention
Not specified
Conditions
Healthy subjects
Sponsor
SHIONOGI & CO., LTD.
Enrollment
15
Status
Completed
Last Updated
2 years ago

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
March 28, 2019
End Date
TBD
Last Updated
2 years ago
Study Type
Interventional
Sex
Male

Investigators

Eligibility Criteria

Inclusion Criteria

  • Healthy adult male subjects between the ages \>\=20 and \<40

Exclusion Criteria

  • The subject who has a history of nervous, gastrointestinal, renal, hepatic, cardiovascular, psychiatric, respiratory, metabolic, endocrine, hematic and other clinically important disorder and were considered ineligible by the investigator or subinvestigator. Subjects whose family has a history of thrombosis, coagulation disorder, or thrombocytosis.

Outcomes

Primary Outcomes

Not specified

Similar Trials